TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4705962
log Bayes Factor = 0.42757
Chromosome 5   position 132,028,858  (GRCh37) Explore rs4705962 on Ensembl!
Variant rs4705962 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
C85.1 B-cell lymphoma, unspecified
0.616 0.384 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.604 0.396 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.604 0.396 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.478 0.522 0.000
C85.0 Lymphosarcoma
0.460 0.540 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.334 0.666 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.165 0.835 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.146 0.854 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.139 0.861 0.000
C88 Malignant immunoproliferative diseases
0.134 0.866 0.000
C83.3 Large cell (diffuse)
0.122 0.878 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.121 0.879 0.000
C86 Other specified types of T/NK-cell lymphoma
0.120 0.879 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.119 0.881 0.000
C91 Lymphoid leukaemia
0.118 0.882 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.117 0.883 0.000
C82.2 Large cell, follicular
0.116 0.883 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.115 0.885 0.000
C82.4 Follicular lymphoma grade IIIb
0.111 0.888 0.000
C94 Other leukaemias of specified cell type
0.110 0.890 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.110 0.890 0.000
C82.0 Small cleaved cell, follicular
0.110 0.890 0.000
C83.7 Burkitt's tumour
0.110 0.890 0.000
C82.3 Follicular lymphoma grade IIIa
0.109 0.891 0.000
C93 Monocytic leukaemia
0.109 0.891 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.107 0.893 0.000
C82.6 Cutaneous follicle centre lymphoma
0.105 0.895 0.000
C82.5 Diffuse follicle centre lymphoma
0.105 0.895 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.104 0.896 0.000
C83.5 Lymphoblastic (diffuse)
0.104 0.896 0.000
C81 Hodgkin's disease
0.102 0.898 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.101 0.899 0.000
C95 Leukaemia of unspecified cell type
0.101 0.899 0.000
C91.4 Hairy-cell leukaemia
0.101 0.899 0.000
C83.6 Undifferentiated (diffuse)
0.100 0.900 0.000
C83.4 Immunoblastic (diffuse)
0.100 0.900 0.000
C83.2 Mixed small and large cell (diffuse)
0.100 0.900 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.096 0.903 0.000
C88.7 Other malignant immunoproliferative diseases
0.096 0.903 0.000
C88.3 Immunoproliferative small intestinal disease
0.096 0.903 0.000
C88.2 Gamma heavy chain disease
0.096 0.903 0.000
C88.1 Alpha heavy chain disease
0.096 0.903 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.092 0.908 0.000
C91.5 Adult T-cell leukaemia
0.089 0.911 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.088 0.911 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.088 0.912 0.000
C90.3 Solitary plasmacytoma
0.087 0.913 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.086 0.913 0.000
C86.4 Blastic NK-cell lymphoma
0.086 0.913 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.086 0.913 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.086 0.913 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.086 0.913 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.086 0.913 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.085 0.914 0.000
C96.8 Histiocytic sarcoma
0.085 0.914 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.085 0.914 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.085 0.914 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.085 0.914 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.085 0.914 0.000
C96.3 True histiocytic lymphoma
0.085 0.914 0.000
C96.2 Malignant mast cell tumour
0.085 0.914 0.000
C96.1 Malignant histiocytosis
0.085 0.914 0.000
C96.0 Letterer-Siwe disease
0.085 0.914 0.000
C91.9 Lymphoid leukaemia, unspecified
0.085 0.915 0.000
C81.2 Mixed cellularity
0.084 0.915 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.084 0.915 0.000
C91.7 Other lymphoid leukaemia
0.084 0.915 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.084 0.915 0.000
C91.3 Prolymphocytic leukaemia
0.084 0.915 0.000
C91.2 Subacute lymphocytic leukaemia
0.084 0.915 0.000
C83.0 Small cell (diffuse)
0.081 0.919 0.000
C91.0 Acute lymphoblastic leukaemia
0.079 0.921 0.000
C94.7 Other specified leukaemias
0.079 0.921 0.000
C94.5 Acute myelofibrosis
0.079 0.921 0.000
C94.3 Mast cell leukaemia
0.079 0.921 0.000
C94.2 Acute megakaryoblastic leukaemia
0.079 0.921 0.000
C94.1 Chronic erythraemia
0.079 0.921 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.079 0.921 0.000
C93.9 Monocytic leukaemia, unspecified
0.078 0.922 0.000
C93.7 Other monocytic leukaemia
0.078 0.922 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.078 0.922 0.000
C93.2 Subacute monocytic leukaemia
0.078 0.922 0.000
C93.0 Acute monocytic leukaemia
0.078 0.922 0.000
C84.4 Peripheral T-cell lymphoma
0.077 0.923 0.000
C84.0 Mycosis fungoides
0.077 0.923 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.077 0.923 0.000
C90.0 Multiple myeloma
0.077 0.923 0.000
C90.2 Plasmacytoma, extramedullary
0.075 0.924 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.075 0.925 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.075 0.925 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.075 0.925 0.000
C84.3 Lymphoepithelioid lymphoma
0.075 0.925 0.000
C84.2 T-zone lymphoma
0.075 0.925 0.000
C84.1 Sezary's diease
0.075 0.925 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.074 0.925 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.073 0.927 0.000
C81.3 Lymphocytic depletion
0.073 0.927 0.000
C81.0 Lymphocytic predominance
0.073 0.927 0.000
C95.7 Other leukaemia of unspecified cell type
0.073 0.927 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.073 0.927 0.000
C94.4 Acute panmyelosis
0.072 0.927 0.000
C81.7 Other Hodgkin's disease
0.071 0.929 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.069 0.931 0.000
C93.1 Chronic monocytic leukaemia
0.068 0.932 0.000
C90.1 Plasma cell leukaemia
0.065 0.935 0.000
C83.1 Small cleaved cell (diffuse)
0.064 0.935 0.000
C95.0 Acute leukaemia of unspecified cell type
0.064 0.936 0.000
C95.9 Leukaemia, unspecified
0.063 0.936 0.000
C81.1 Nodular sclerosis
0.061 0.939 0.000
C84.5 Other and unspecified T-cell lymphomas
0.059 0.941 0.000
C81.9 Hodgkin's disease, unspecified
0.053 0.947 0.000
C34.1 Upper lobe, bronchus or lung
0.052 0.948 0.000
K50.0 Crohn's disease of small intestine
0.051 0.949 0.000
K50 Crohn's disease [regional enteritis]
0.050 0.950 0.000
C34 Malignant neoplasm of bronchus and lung
0.049 0.951 0.000
C91.1 Chronic lymphocytic leukaemia
0.049 0.951 0.000
K50.1 Crohn's disease of large intestine
0.048 0.952 0.000
K50.9 Crohn's disease, unspecified
0.046 0.954 0.000
C34.3 Lower lobe, bronchus or lung
0.045 0.955 0.000
S72.00 Fracture of neck of femur (closed)
0.044 0.956 0.000
K50.8 Other Crohn's disease
0.044 0.956 0.000
C34.0 Main bronchus
0.042 0.958 0.000
C34.9 Bronchus or lung, unspecified
0.042 0.958 0.000
C34.2 Middle lobe, bronchus or lung
0.040 0.960 0.000
C34.8 Overlapping lesion of bronchus and lung
0.038 0.962 0.000
C92 Myeloid leukaemia
0.034 0.965 0.001
C92.9 Myeloid leukaemia, unspecified
0.027 0.973 0.001
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.025 0.975 0.001
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.025 0.975 0.001
C92.3 Myeloid sarcoma
0.025 0.975 0.001
C92.2 Subacute myeloid leukaemia
0.025 0.975 0.001
C92.4 Acute promyelocytic leukaemia
0.023 0.976 0.001
C92.5 Acute myelomonocytic leukaemia
0.022 0.977 0.001
S72.0 Fracture of neck of femur
0.022 0.978 0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s
0.000 0.979 0.021
C92.7 Other myeloid leukaemia
0.019 0.980 0.001
M19.01 Primary arthrosis of other joints (Shoulder region)
0.000 0.983 0.017
S72.01 Fracture of neck of femur (open)
0.016 0.984 0.000
N41.0 Acute prostatitis
0.016 0.984 0.000
C92.0 Acute myeloid leukaemia
0.014 0.986 0.001
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.014 0.986 0.000
H11.3 Conjunctival haemorrhage
0.013 0.987 0.000
M54.57 Low back pain (Lumbosacral region)
0.000 0.988 0.012
M53.3 Sacrococcygeal disorders, not elsewhere classified
0.000 0.988 0.012
C37 Malignant neoplasm of thymus
0.011 0.989 0.000
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung
0.010 0.990 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.010 0.990 0.000
C33 Malignant neoplasm of trachea
0.010 0.990 0.000
D23.1 Skin of eyelid, including canthus
0.000 0.990 0.010
C38 Malignant neoplasm of heart, mediastinum and pleura
0.010 0.990 0.000
C31 Malignant neoplasm of accessory sinuses
0.010 0.990 0.000
C92.1 Chronic myeloid leukaemia
0.008 0.990 0.001
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns
0.000 0.991 0.009
C30 Malignant neoplasm of nasal cavity and middle ear
0.009 0.991 0.000
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac
0.000 0.991 0.009
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar
0.000 0.991 0.009
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol
0.000 0.991 0.009
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic
0.000 0.991 0.009
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot
0.000 0.991 0.009
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical
0.000 0.991 0.009
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-
0.000 0.991 0.009
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit
0.000 0.991 0.009
H11 Other disorders of conjunctiva
0.008 0.992 0.000
H11.0 Pterygium
0.008 0.992 0.000
C32 Malignant neoplasm of larynx
0.008 0.992 0.000
C39.9 Ill-defined sites within the respiratory system
0.007 0.992 0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.007 0.992 0.000
C39.0 Upper respiratory tract, part unspecified
0.007 0.992 0.000
K50-K52 Noninfective enteritis and colitis
0.008 0.992 0.000
N13.3 Other and unspecified hydronephrosis
0.007 0.993 0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.007 0.993 0.000
C38.2 Posterior mediastinum
0.007 0.993 0.000
C38.1 Anterior mediastinum
0.007 0.993 0.000
C38.0 Heart
0.007 0.993 0.000
C31.9 Accessory sinus, unspecified
0.007 0.993 0.000
C31.8 Overlapping lesion of accessory sinuses
0.007 0.993 0.000
C31.3 Sphenoidal sinus
0.007 0.993 0.000
C31.2 Frontal sinus
0.007 0.993 0.000
C31.1 Ethmoidal sinus
0.007 0.993 0.000
C38.4 Pleura
0.007 0.993 0.000
C38.3 Mediastinum, part unspecified
0.007 0.993 0.000
H11.1 Conjunctival degenerations and deposits
0.007 0.993 0.000
C31.0 Maxillary sinus
0.007 0.993 0.000
C30.1 Middle ear
0.006 0.993 0.000
H11.9 Disorder of conjunctiva, unspecified
0.007 0.993 0.000
I85.9 Oesophageal varices without bleeding
0.007 0.993 0.000
Z35.0 Supervision of pregnancy with history of infertility
0.007 0.993 0.000
S72 Fracture of femur
0.006 0.994 0.000
C32.3 Laryngeal cartilage
0.006 0.994 0.000
Z35.5 Supervision of elderly primigravida
0.006 0.994 0.000
X62.9 Unspecified place
0.000 0.994 0.006
H53.8 Other visual disturbances
0.000 0.994 0.006
Z35 Supervision of high-risk pregnancy
0.006 0.994 0.000
C32.8 Overlapping lesion of larynx
0.006 0.994 0.000
C32.2 Subglottis
0.006 0.994 0.000
H11.2 Conjunctival scars
0.006 0.994 0.000
T40.2 Other opioids
0.000 0.994 0.006
C32.9 Larynx, unspecified
0.006 0.994 0.000
Z35.8 Supervision of other high-risk pregnancies
0.006 0.994 0.000
C32.1 Supraglottis
0.006 0.994 0.000
K51.4 Pseudopolyposis of colon
0.006 0.994 0.000
C30.0 Nasal cavity
0.005 0.994 0.000
S72.2 Subtrochanteric fracture
0.005 0.995 0.000
H11.8 Other specified disorders of conjunctiva
0.005 0.995 0.000
D07.5 Prostate
0.005 0.995 0.000
S72.7 Multiple fractures of femur
0.005 0.995 0.000
Z35.9 Supervision of high-risk pregnancy, unspecified
0.005 0.995 0.000
K51 Ulcerative colitis
0.005 0.995 0.000
S72.8 Fractures of other parts of femur
0.005 0.995 0.000
M53 Other dorsopathies, not elsewhere classified
0.000 0.995 0.005
O20.9 Haemorrhage in early pregnancy, unspecified
0.005 0.995 0.000
M25.75 Osteophyte (Pelvic region and thigh)
0.005 0.995 0.000
N13.6 Pyonephrosis
0.005 0.995 0.000
Z35.7 Supervision of high-risk pregnancy due to social problems
0.004 0.995 0.000
Z35.6 Supervision of very young primigravida
0.004 0.995 0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care
0.004 0.995 0.000
N13.8 Other obstructive and reflux uropathy
0.005 0.995 0.000
S72.20 Subtrochanteric fracture (closed)
0.004 0.995 0.000
K51.1 Ulcerative (chronic) ileocolitis
0.004 0.996 0.000
S72.9 Fracture of femur, part unspecified
0.004 0.996 0.000
S72.3 Fracture of shaft of femur
0.004 0.996 0.000
E27.1 Primary adrenocortical insufficiency
0.004 0.996 0.000
Z35.4 Supervision of pregnancy with grand multiparity
0.004 0.996 0.000
S72.4 Fracture of lower end of femur
0.004 0.996 0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history
0.004 0.996 0.000
S72.70 Multiple fractures of femur (closed)
0.004 0.996 0.000
N13 Obstructive and reflux uropathy
0.004 0.996 0.000
S72.21 Subtrochanteric fracture (open)
0.004 0.996 0.000
H73.8 Other specified disorders of tympanic membrane
0.004 0.996 0.000
K51.8 Other ulcerative colitis
0.004 0.996 0.000
Z35.1 Supervision of pregnancy with history of abortive outcome
0.004 0.996 0.000
I12.9 Hypertensive renal disease without renal failure
0.004 0.996 0.000
S72.71 Multiple fractures of femur (open)
0.004 0.996 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.996 0.004
M53.9 Dorsopathy, unspecified
0.000 0.996 0.004
S72.81 Fractures of other parts of femur (open)
0.004 0.996 0.000
M50.1 Cervical disk disorder with radiculopathy
0.004 0.996 0.000
M53.1 Cervicobrachial syndrome
0.000 0.996 0.004
M53.0 Cervicocranial syndrome
0.000 0.996 0.004
S72.1 Pertrochanteric fracture
0.004 0.996 0.000
S72.80 Fractures of other parts of femur (closed)
0.003 0.996 0.000
D23.5 Skin of trunk
0.000 0.996 0.004
A49.8 Other bacterial infections of unspecified site
0.000 0.996 0.004
D22.9 Melanocytic naevi, unspecified
0.000 0.996 0.004
H52.2 Astigmatism
0.004 0.996 0.000
C32.0 Glottis
0.003 0.996 0.000
N13.7 Vesicoureteral-reflux-associated uropathy
0.004 0.996 0.000
K51.3 Ulcerative (chronic) rectosigmoiditis
0.004 0.996 0.000
M53.8 Other specified dorsopathies
0.000 0.996 0.003
M53.2 Spinal instabilities
0.000 0.996 0.003
N13.9 Obstructive and reflux uropathy, unspecified
0.004 0.996 0.000
H11.4 Other conjunctival vascular disorders and cysts
0.003 0.997 0.000
S72.91 Fracture of femur, part unspecified (open)
0.003 0.997 0.000
S72.41 Fracture of lower end of femur (open)
0.003 0.997 0.000
K51.9 Ulcerative colitis, unspecified
0.003 0.997 0.000
H10-H13 Disorders of conjunctiva
0.003 0.997 0.000
T40.1 Heroin
0.000 0.997 0.003
O24.4 Diabetes mellitus arising in pregnancy
0.003 0.997 0.000
S72.31 Fracture of shaft of femur (open)
0.003 0.997 0.000
D23.9 Skin, unspecified
0.000 0.997 0.003
T40.3 Methadone
0.000 0.997 0.003
Y57.9 Drug or medicament, unspecified
0.000 0.997 0.003
N64.8 Other specified disorders of breast
0.000 0.997 0.003
A49.2 Haemophilus influenzae infection, unspecified
0.000 0.997 0.003
D23 Other benign neoplasms of skin
0.000 0.997 0.003
D40.0 Prostate
0.003 0.997 0.000
T40.5 Cocaine
0.000 0.997 0.003
M53.96 Dorsopathy, unspecified (Lumbar region)
0.000 0.997 0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.997 0.003
T40.8 Lysergide [LSD]
0.000 0.997 0.003
T40.7 Cannabis (derivatives)
0.000 0.997 0.003
T40.0 Opium
0.000 0.997 0.003
D48.6 Breast
0.003 0.997 0.000
N64.5 Other signs and symptoms in breast
0.000 0.997 0.003
O26.9 Pregnancy-related condition, unspecified
0.003 0.997 0.000
M53.99 Dorsopathy, unspecified (Site unspecified)
0.000 0.997 0.003
M53.98 Dorsopathy, unspecified (Sacral and sacrococcygeal region)
0.000 0.997 0.003
M53.97 Dorsopathy, unspecified (Lumbosacral region)
0.000 0.997 0.003
M53.95 Dorsopathy, unspecified (Thoracolumbar region)
0.000 0.997 0.003
M53.94 Dorsopathy, unspecified (Thoracic region)
0.000 0.997 0.003
M53.93 Dorsopathy, unspecified (Cervicothoracic region)
0.000 0.997 0.003
M53.92 Dorsopathy, unspecified (Cervical region)
0.000 0.997 0.003
M53.91 Dorsopathy, unspecified (Occipito-atlanto-axial region)
0.000 0.997 0.003
M53.90 Dorsopathy, unspecified (Multiple sites in spine)
0.000 0.997 0.003
M53.09 Cervicocranial syndrome-Site unspe
0.000 0.997 0.003
M53.08 Cervicocranial syndrome-Sacral/sacrococ
0.000 0.997 0.003
M53.07 Cervicocranial syndrome-Lumbosacral
0.000 0.997 0.003
M53.06 Cervicocranial syndrome-Lumbar
0.000 0.997 0.003
M53.05 Cervicocranial syndrome-Thoracolumbar
0.000 0.997 0.003
M53.04 Cervicocranial syndrome-Thoracic
0.000 0.997 0.003
M53.03 Cervicocranial syndrome (Cervicothoracic region)
0.000 0.997 0.003
M53.02 Cervicocranial syndrome (Cervical region)
0.000 0.997 0.003
M53.01 Cervicocranial syndrome (Occipito-atlanto-axial region)
0.000 0.997 0.003
M53.00 Cervicocranial syndrome (Multiple sites in spine)
0.000 0.997 0.003
M53.19 Cervicobrachial syndrome-Site unspe
0.000 0.997 0.003
M53.18 Cervicobrachial syndrome-Sacral/sacrococ
0.000 0.997 0.003
M53.17 Cervicobrachial syndrome-Lumbosacral
0.000 0.997 0.003
M53.16 Cervicobrachial syndrome-Lumbar
0.000 0.997 0.003
M53.15 Cervicobrachial syndrome-Thoracolumbar
0.000 0.997 0.003
M53.14 Cervicobrachial syndrome-Thoracic
0.000 0.997 0.003
M53.13 Cervicobrachial syndrome (Cervicothoracic region)
0.000 0.997 0.003
M53.12 Cervicobrachial syndrome (Cervical region)
0.000 0.997 0.003
M53.11 Cervicobrachial syndrome (Occipito-atlanto-axial region)
0.000 0.997 0.003
M53.10 Cervicobrachial syndrome (Multiple sites in spine)
0.000 0.997 0.003
S72.90 Fracture of femur, part unspecified (closed)
0.003 0.997 0.000
S72.11 Pertrochanteric fracture (open)
0.003 0.997 0.000
M53.22 Spinal instabilities (Cervical region)
0.000 0.997 0.003
K51.5 Mucosal proctocolitis
0.003 0.997 0.000
S72.30 Fracture of shaft of femur (closed)
0.003 0.997 0.000
T40.6 Other and unspecified narcotics
0.000 0.997 0.003
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.000 0.997 0.003
O24 Diabetes mellitus in pregnancy
0.003 0.997 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.997 0.003
M53.89 Other specified dorsopathies (Site unspecified)
0.000 0.997 0.003
M53.88 Other specified dorsopathies (Sacral and sacrococcygeal region)
0.000 0.997 0.003
M53.87 Other specified dorsopathies (Lumbosacral region)
0.000 0.997 0.003
M53.85 Other specified dorsopathies (Thoracolumbar region)
0.000 0.997 0.003
M53.84 Other specified dorsopathies (Thoracic region)
0.000 0.997 0.003
M53.83 Other specified dorsopathies (Cervicothoracic region)
0.000 0.997 0.003
M53.81 Other specified dorsopathies (Occipito-atlanto-axial region)
0.000 0.997 0.003
M53.80 Other specified dorsopathies (Multiple sites in spine)
0.000 0.997 0.003
M53.29 Spinal instabilities (Site unspecified)
0.000 0.997 0.003
M53.28 Spinal instabilities (Sacral and sacrococcygeal region)
0.000 0.997 0.003
M53.27 Spinal instabilities (Lumbosacral region)
0.000 0.997 0.003
M53.25 Spinal instabilities (Thoracolumbar region)
0.000 0.997 0.003
M53.24 Spinal instabilities (Thoracic region)
0.000 0.997 0.003
M53.23 Spinal instabilities (Cervicothoracic region)
0.000 0.997 0.003
M53.21 Spinal instabilities (Occipito-atlanto-axial region)
0.000 0.997 0.003
M53.20 Spinal instabilities (Multiple sites in spine)
0.000 0.997 0.003
H13 Disorders of conjunctiva in diseases classified elsewhere
0.003 0.997 0.000
M53.82 Other specified dorsopathies (Cervical region)
0.000 0.997 0.003
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.000 0.997 0.003
A49 Bacterial infection of unspecified site
0.000 0.997 0.003
M53.86 Other specified dorsopathies (Lumbar region)
0.000 0.997 0.002
T51.0 Ethanol
0.000 0.997 0.003
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.997 0.003
N64.9 Disorder of breast, unspecified
0.000 0.997 0.003
O24.0 Pre-existing diabetes mellitus, insulin-dependent
0.003 0.997 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.003 0.997 0.000
T46.1 Calcium-channel blockers
0.000 0.997 0.003
I85 Oesophageal varices
0.003 0.997 0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction
0.003 0.997 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.003 0.997 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.997 0.003
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.997 0.003
D23.6 Skin of upper limb, including shoulder
0.000 0.997 0.003
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.997 0.003
M18.9 Arthrosis of first carpometacarpal joint, unspecified
0.000 0.997 0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.997 0.003
M53.26 Spinal instabilities (Lumbar region)
0.000 0.997 0.002
C17.9 Small intestine, unspecified
0.003 0.997 0.000
T36 Poisoning by systemic antibiotics
0.000 0.997 0.003
T36.0 Penicillins
0.000 0.997 0.002
C17.2 Ileum
0.002 0.997 0.000
H13.3 Ocular pemphigoid
0.002 0.997 0.000
O24.9 Diabetes mellitus in pregnancy, unspecified
0.002 0.998 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.998 0.002
A49.1 Streptococcal infection, unspecified
0.000 0.998 0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.998 0.002
D40.1 Testis
0.002 0.998 0.000
D48.7 Other specified sites
0.002 0.998 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.998 0.002
N13.5 Kinking and stricture of ureter without hydronephrosis
0.002 0.998 0.000
D48.5 Skin
0.002 0.998 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.998 0.002
N64 Other disorders of breast
0.000 0.998 0.002
D48.0 Bone and articular cartilage
0.002 0.998 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.998 0.002
D23.2 Skin of ear and external auricular canal
0.000 0.998 0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.998 0.002
T47.2 Stimulant laxatives
0.000 0.998 0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.998 0.002
M17.0 Primary gonarthrosis, bilateral
0.002 0.998 0.000
N13.4 Hydroureter
0.002 0.998 0.000
T42.0 Hydantoin derivatives
0.000 0.998 0.002
S72.40 Fracture of lower end of femur (closed)
0.002 0.998 0.000
X62.0 Home
0.000 0.998 0.002
X62.7 Farm
0.000 0.998 0.002
X62.6 Industrial and construction area
0.000 0.998 0.002
X62.5 Trade and service area
0.000 0.998 0.002
X62.4 Street and highway
0.000 0.998 0.002
X62.3 Sports and athletics area
0.000 0.998 0.002
X62.2 School, other institution and public administrative area
0.000 0.998 0.002
X62.1 Residential institution
0.000 0.998 0.002
O24.3 Pre-existing diabetes mellitus, unspecified
0.002 0.998 0.000
O24.2 Pre-existing malnutrition-related diabetes mellitus
0.002 0.998 0.000
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent
0.002 0.998 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.998 0.002
T46.7 Peripheral vasodilators
0.000 0.998 0.002
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.998 0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.998 0.002
G54.0 Brachial plexus disorders
0.000 0.998 0.002
H13.8 Other disorders of conjunctiva in diseases classified elsewhere
0.002 0.998 0.000
H13.2 Conjunctivitis in other diseases classified elsewhere
0.002 0.998 0.000
H13.0 Filarial infection of conjunctiva
0.002 0.998 0.000
H10 Conjunctivitis
0.002 0.998 0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)
0.002 0.998 0.000
A49.3 Mycoplasma infection, unspecified
0.000 0.998 0.002
Q76.0 Spina bifida occulta
0.002 0.998 0.000
O20 Haemorrhage in early pregnancy
0.002 0.998 0.000
M79.69 Pain in limb (Site unspecified)
0.000 0.998 0.002
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere
0.002 0.998 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.998 0.002
D39.1 Ovary
0.002 0.998 0.000
A49.9 Bacterial infection, unspecified
0.000 0.998 0.002
D40.9 Male genital organ, unspecified
0.002 0.998 0.000
D40.7 Other male genital organs
0.002 0.998 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.998 0.002
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.002 0.998 0.000
C17 Malignant neoplasm of small intestine
0.002 0.998 0.000
D48.3 Retroperitoneum
0.002 0.998 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.998 0.002
T48.4 Expectorants
0.000 0.998 0.002
T48.3 Antitussives
0.000 0.998 0.002
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.998 0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.998 0.002
T48.0 Oxytocic drugs
0.000 0.998 0.002
D23.0 Skin of lip
0.000 0.998 0.002
X62.8 Other specified place
0.000 0.998 0.002
T36.8 Other systemic antibiotics
0.000 0.998 0.002
T36.4 Tetracyclines
0.000 0.998 0.002
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.998 0.002
R49.0 Dysphonia
0.000 0.998 0.002
T48.5 Anti-common-cold drugs
0.000 0.998 0.002
Y57.5 X-ray contrast media
0.000 0.998 0.002
T36.9 Systemic antibiotic, unspecified
0.000 0.998 0.002
T36.7 Antifungal antibiotics, systemically used
0.000 0.998 0.002
T36.6 Rifamycins
0.000 0.998 0.002
T36.5 Aminoglycosides
0.000 0.998 0.002
T36.2 Chloramphenicol group
0.000 0.998 0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.998 0.002
T42.1 Iminostilbenes
0.000 0.998 0.002
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.998 0.002
D48.4 Peritoneum
0.002 0.998 0.000
T40.4 Other synthetic narcotics
0.000 0.998 0.002
Y57 Other and unspecified drugs and medicaments
0.000 0.998 0.002
R44.1 Visual hallucinations
0.000 0.998 0.002
D37-D48 Neoplasms of uncertain or unknown behaviour
0.002 0.998 0.000
G60.0 Hereditary motor and sensory neuropathy
0.002 0.998 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.998 0.002
T47.4 Other laxatives
0.000 0.998 0.002
C17.1 Jejunum
0.002 0.998 0.000
K51.0 Ulcerative (chronic) enterocolitis
0.002 0.998 0.000
T36.3 Macrolides
0.000 0.998 0.002
D39.0 Uterus
0.002 0.998 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.002 0.998 0.000
I85.0 Oesophageal varices with bleeding
0.002 0.998 0.000
N64.3 Galactorrhoea not associated with childbirth
0.000 0.998 0.002
N64.0 Fissure and fistula of nipple
0.000 0.998 0.002
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.998 0.002
T42.2 Succinimides and oxazolidinediones
0.000 0.998 0.002
T43.6 Psychostimulants with abuse potential
0.000 0.998 0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.998 0.002
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.998 0.002
T47.7 Emetics
0.000 0.998 0.002
T47.5 Digestants
0.000 0.998 0.002
T47.3 Saline and osmotic laxatives
0.000 0.998 0.002
Y57.8 Other drugs and medicaments
0.000 0.998 0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.998 0.002
D04.2 Skin of ear and external auricular canal
0.002 0.998 0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.002 0.998 0.000
D48.1 Connective and other soft tissue
0.002 0.998 0.000
H10.8 Other conjunctivitis
0.002 0.998 0.000
H10.4 Chronic conjunctivitis
0.002 0.998 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.002 0.998 0.000
H73 Other disorders of tympanic membrane
0.002 0.998 0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity
0.000 0.998 0.002
C17.0 Duodenum
0.002 0.998 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.998 0.002
T47.0 Histamine H(2)-receptor antagonists
0.000 0.998 0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.998 0.002
D38.1 Trachea, bronchus and lung
0.002 0.998 0.000
N64.2 Atrophy of breast
0.000 0.998 0.002
R49.8 Other and unspecified voice disturbances
0.000 0.998 0.002
T41.2 Other and unspecified general anaesthetics
0.000 0.998 0.002
D48.2 Peripheral nerves and autonomic nervous system
0.002 0.998 0.000
H10.3 Acute conjunctivitis, unspecified
0.002 0.998 0.000
H10.2 Other acute conjunctivitis
0.002 0.998 0.000
H73.9 Disorder of tympanic membrane, unspecified
0.002 0.998 0.000
T47.6 Antidiarrhoeal drugs
0.000 0.998 0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.998 0.002
T41.5 Therapeutic gases
0.000 0.998 0.002
T41.4 Anaesthetic, unspecified
0.000 0.998 0.002
T41.3 Local anaesthetics
0.000 0.998 0.002
T41.1 Intravenous anaesthetics
0.000 0.998 0.002
T41.0 Inhaled anaesthetics
0.000 0.998 0.002
A49.0 Staphylococcal infection, unspecified
0.000 0.998 0.002
H10.5 Blepharoconjunctivitis
0.002 0.998 0.000
J34.0 Abscess, furuncle and carbuncle of nose
0.000 0.998 0.002
T43.9 Psychotropic drug, unspecified
0.000 0.998 0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.998 0.002
D39.9 Female genital organ, unspecified
0.002 0.998 0.000
D39.2 Placenta
0.002 0.998 0.000
C17.8 Overlapping lesion of small intestine
0.002 0.998 0.000
C17.3 Meckel's diverticulum
0.002 0.998 0.000
H10.0 Mucopurulent conjunctivitis
0.002 0.998 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.998 0.002
Z47.8 Other specified orthopaedic follow-up care
0.002 0.998 0.000
O20-O29 Other maternal disorders predominantly related to pregnancy
0.002 0.998 0.000
D39.7 Other female genital organs
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.